Back to search

Rhino Therapeutics Limited

14604755

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

FOURTH FLOOR ST JAMES HOUSE, CHELTENHAM, GL50 3PR
Incorporated 19/01/2023

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 18/01/2026

Due 01/02/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Andrew William Mulvaney

director · Since 02/02/2026

BRITISH · ENGLAND · Age 56

Also on 1 other board

Mr Kleanthis Gabriel Xanthopoulos

director · Since 23/02/2026

AMERICAN · UNITED STATES · Age 68

Persons with Significant Control

Former PSCs

Dr Graham Michael Wynne

Ceased 18/07/2023

CompanyRankvs 566+ SIC 72110 peers
71

Financial strength93th percentile among SIC peers · 23/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 2.23× · 20/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£1.2M

Balance sheet strength

Cash

£745k

Cash in the bank

Net Current Assets

£1.2M

Working capital

Current Assets

£2.2M

Current Liabilities

£973k

Fixed Assets

£1k

Debtors

£1.4M

2avg. employees

Tax at Year End

Corp tax£183k

Balance Sheet

Assets less current liabilities£1.2M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20252.23+£538k
20252.08+£448k
20241.27

Derived from filed accounts. Not audited figures.